Money Concepts Capital’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
Money Concepts Capital's IBB Position: Q2 2026 in Review
Money Concepts Capital increased its iShares Biotechnology ETF (IBB) stake by 12% in Q2 2026, buying an estimated $32.7K and bringing the position to 1,735 shares worth $330K. The position accounts for 0.02% of the portfolio, ranked #498.
Money Concepts Capital first reported a position in IBB in Q4 2020 and has held it in 16 quarters since. The position peaked at $441K in Q1 2022. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Money Concepts Capital held 1,735 shares of iShares Biotechnology ETF worth $330K as of Q2 2026.
- Money Concepts Capital bought 190 iShares Biotechnology ETF shares in Q2 2026, an estimated $32.7K.
- iShares Biotechnology ETF made up 0.02% of Money Concepts Capital's portfolio in Q2 2026, its #498 holding.
- Money Concepts Capital first reported a position in iShares Biotechnology ETF in Q4 2020 and has held it in 16 quarters since.
- Money Concepts Capital's iShares Biotechnology ETF position peaked at $441K in Q1 2022.
- 960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Money Concepts Capital's 13F filing for Q2 2026, filed 4 Aug 2026.